Gene · 2931
Papers2,889
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,889
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AKT inhibitors in gynecologic oncology: past, present and future. | Front Oncol | 2025 | 40746599 | PubTator, text mining | PubMed |
| Unraveling mitochondrial crosstalk: a new frontier in heart failure pathogenesis. | Front Cardiovasc Med | 2025 | 40734976 | PubTator, text mining | PubMed |
| Impact of Gemin5 in protein synthesis: phosphoresidues of the dimerization domain regulate ribosome binding. | RNA Biol | 2025 | 40734649 | PubTator, text mining | PubMed |
| Differential impact of hepatitis delta virus replication and expression of viral antigens on the cellular kinome profile. | Cell Commun Signal | 2025 | 40537790 | PubTator, text mining | PubMed |
| GSK3A promotes human adenovirus replication and phosphorylates viral L4-22K protein. | Life Sci Alliance | 2025 | 40537285 | PubTator, text mining | PubMed |
| The ubiquitin ligase HUWE1 enhances WNT signaling by antagonizing destruction complex-mediated β-catenin degradation and through a mechanism independent of changes in β-catenin abundance. | PLoS Genet | 2025 | 40424469 | PubTator, text mining | PubMed |
| Novel Tricyclic Compounds as GSK3 Inhibitors. | ACS Med Chem Lett | 2025 | 40365405 | PubTator, text mining | PubMed |
| The Application of Non-Coding RNAs as Biomarkers, Therapies, and Novel Vaccines in Diseases. | Int J Mol Sci | 2025 | 40243658 | PubTator, text mining | PubMed |
Structure-Based Discovery Targeting GSK-3α Reveals Potent Nanomolar Selective 4-Phenyl-1H-benzofuro[3,2-b]pyrazolo[4,3-e]pyridine Inhibitor with Promising Glioblastoma and CNS-Active Potential in Cellular Models. | J Med Chem | 2025 | 40198746 | PubTator, text mining | PubMed |
| Probe-dependent Proximity Profiling (ProPPr) Uncovers Similarities and Differences in Phospho-Tau-Associated Proteomes Between Tauopathies. | Mol Neurodegener | 2025 | 40082954 | PubTator, text mining | PubMed |
| Proteome-wide Mendelian randomization identifies causal plasma proteins in prostate cancer development. | Hum Genomics | 2025 | 39994764 | PubTator, text mining | PubMed |
| Comparative RNA-Seq analysis of differentially expressed genes in the sertoli cells of yak and cattle-yak. | BMC Vet Res | 2025 | 39987073 | PubTator, text mining | PubMed |
| The Abnormal ERα-miRNA Cross-Talk in AD-Affected Human Hippocampus: A Bioinformatics Perspective. | Mol Neurobiol | 2025 | 39966328 | PubTator, text mining | PubMed |
| Tacrolimus induces insulin receptor substrate 1 hyperphosphorylation and inhibits mTORc1/S6K1 cascade in HL7702 cells. | World J Diabetes | 2025 | 39959267 | PubTator, text mining | PubMed |
| A non-hormonal reversible contraceptive targeting GSK3α, a protein kinase, essential for epididymal sperm maturation. | Andrology | 2025 | 39748754 | PubTator, text mining | PubMed |
| QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular age-related macular degeneration. | Br J Pharmacol | 2025 | 39428594 | PubTator, text mining | PubMed |
| Isoindolinedione-Benzamide Pyridinium Derivatives for Targeting Alzheimer's Disease. | ACS Omega | 2024 | 39676969 | PubTator, text mining | PubMed |
| Characterization of the BH1406 non-small cell lung cancer (NSCLC) cell line carrying an activating SOS1 mutation. | Transl Lung Cancer Res | 2024 | 39670010 | PubTator, text mining | PubMed |
| Large-scale characterization of drug mechanism of action using proteome-wide thermal shift assays. | Elife | 2024 | 39526730 | PubTator, text mining | PubMed |
| Distinct Hippocampal Expression Profiles of lncRNAs in Obese Type 2 Diabetes Mice Exhibiting Cognitive Impairment. | Neuromolecular Med | 2024 | 39470862 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2931/papers?page=3